ALHC
Alignment Healthcare, Inc.
NASDAQ · Healthcare · Medical - Healthcare Plans · US
$7.74
+4.69%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 4.9B | 3.9B | 2.7B | 1.8B | 1.4B |
| Cost of Revenue | 4.4B | 3.5B | 2.4B | 1.6B | 1.2B |
| Gross Profit | 589.4M | 488.6M | 296.7M | 201.0M | 184.3M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 388.5M | — | 371.4M | 307.4M | 295.6M |
| General & Admin Expense | 136.4M | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 157.4M | 473.8M | 26.9M | 21.4M | 17.3M |
| Total Operating Expenses | 545.9M | 473.8M | 398.2M | 328.8M | 312.9M |
| Cost and Expenses | 4.9B | 3.9B | 2.8B | 2.0B | 1.6B |
| Operating Income (EBIT) | 43.5M | 14.8M | (101.6M) | (127.8M) | (128.6M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 16.6M | 15.8M | 23.5M | 21.2M | 18.3M |
| Net Interest Income | (16.6M) | (15.8M) | (23.5M) | (21.2M) | (18.3M) |
| Other Non-Op Income/Expense | (16.6M) | (15.7M) | (26.5M) | (20.4M) | (20.7M) |
| Non-Operating Income (excl Interest) | (1.0K) | (89.0K) | 2.9M | (853.0K) | 2.4M |
| EBT (Pre-Tax Income) | 27.0M | (958.0K) | (128.1M) | (148.2M) | (149.3M) |
| Income Tax Expense | (2.0M) | 20.0K | 21.0K | (22.0K) | 339.0K |
| Bottom Line | |||||
| Net Income | 28.9M | (724.0K) | (128.0M) | (148.0M) | (149.5M) |
| Earnings from Cont. Ops | 28.9M | (978.0K) | (128.1M) | (148.2M) | (149.6M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 28.9M | (724.0K) | (128.0M) | (148.0M) | (149.5M) |
| Per Share | |||||
| Basic EPS | $0.14 | ($0.00) | ($0.67) | ($0.79) | ($0.83) |
| Diluted EPS | $0.13 | ($0.00) | ($0.67) | ($0.79) | ($0.83) |
| Revenue Per Share | $23.70 | $19.94 | $14.17 | $9.79 | $7.91 |
| Shares | |||||
| Basic Shares Outstanding | 208.6M | 198.0M | 190.8M | 186.2M | 181.2M |
| Diluted Shares Outstanding | 208.6M | 198.0M | 190.8M | 186.2M | 181.2M |
| Profitability Metrics | |||||
| EBITDA | 75.2M | 45.3M | (77.4M) | (105.3M) | (113.5M) |
| D&A | 31.7M | 30.5M | 27.1M | 21.7M | 17.5M |
| EBIT | 43.5M | 14.8M | (104.5M) | (127.0M) | (131.0M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026